Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
171.81
-1.18 (-0.68%)
At close: Apr 23, 2026

EGX:MPCI Income Statement

Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Revenue
1,6751,508871.91663.83551.26518.11
1,6751,508871.91663.83551.26518.11
Revenue Growth (YoY)
36.21%72.93%31.34%20.42%6.40%6.08%
Cost of Revenue
990.33827.82571.62450.88401.87353.14
Gross Profit
685.08679.98300.29212.95149.39164.98
Selling, General & Admin
99.0899.0286.1977.4171.875.98
Other Operating Expenses
57.9458.612.6939.658.5554.86
Operating Expenses
157.02157.6388.88117.0680.35130.84
Operating Income
528.06522.35211.4195.8969.0434.13
Interest Expense
-8.16-13.51-14.26---
Interest & Investment Income
129.78136.4755.6511.137.285.41
Currency Exchange Gain (Loss)
15.72---0.67-
Other Non Operating Income (Expenses)
4.636.56-23.292.961.342.11
EBT Excluding Unusual Items
670.03651.87229.52109.9878.3241.65
Gain (Loss) on Sale of Assets
0.440.44----
Pretax Income
670.46652.3229.52109.9878.3241.65
Income Tax Expense
151.49147.0238.0619.554.23-0.15
Net Income
518.98505.28191.4690.4474.0941.81
Net Income to Common
518.98505.28191.4690.4474.0941.81
Net Income Growth
37.79%163.91%111.70%22.07%77.22%140.14%
Shares Outstanding (Basic)
2323666-
Shares Outstanding (Diluted)
2323666-
Shares Change (YoY)
304.44%304.44%----
EPS (Basic)
22.8122.2134.0416.0813.17-
EPS (Diluted)
22.8122.2134.0416.0813.17-
EPS Growth
-65.93%-34.75%111.70%22.07%--
Free Cash Flow
-103.1365.65158.8346.4923.551.4
Free Cash Flow Per Share
-4.532.8928.248.274.19-
Dividend Per Share
13.18713.1874.0002.000--
Dividend Growth
229.67%229.67%100.00%---
Gross Margin
40.89%45.10%34.44%32.08%27.10%31.84%
Operating Margin
31.52%34.64%24.25%14.45%12.52%6.59%
Profit Margin
30.98%33.51%21.96%13.62%13.44%8.07%
Free Cash Flow Margin
-6.16%4.35%18.22%7.00%4.27%0.27%
EBITDA
548.96542.17223.59103.6576.6843.88
EBITDA Margin
32.77%35.96%25.64%15.61%13.91%8.47%
D&A For EBITDA
20.8919.8212.187.757.649.74
EBIT
528.06522.35211.4195.8969.0434.13
EBIT Margin
31.52%34.64%24.25%14.45%12.52%6.59%
Effective Tax Rate
22.59%22.54%16.58%17.77%5.40%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.